LNTH NASDAQ
Lantheus Holdings, Inc.
1W: +0.2%
1M: -0.8%
3M: -2.8%
YTD: +48.6%
1Y: +93.6%
3Y: +51.7%
5Y: +270.6%
$99.96
+0.31 (+0.31%)
Weekly Expected Move ±0.5%
$99
$99
$100
$101
$101
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (60)
Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Rated “Hold” by Wall Street Analysts
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
Lantheus gains approval of Bravnesta, generic competitor to Lutathera
Lantheus withdraws, resubmits HSR filing for Curium acquisition
Baird Financial Group Inc. Has $3.26 Million Position in Lantheus Holdings, Inc. $LNTH
Novartis' Lutathera now facing generic competition from Cirium's Bexlutry
California State Teachers Retirement System Purchases 8,356,007 Shares of Lantheus Holdings, Inc. $LNTH
Hsbc Holdings PLC Invests $2.27 Million in Lantheus Holdings, Inc. $LNTH
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and more
First Trust Advisors LP Purchases 44,713 Shares of Lantheus Holdings, Inc. $LNTH
Curium Announces Definitive Agreement to Merge with Lantheus
Key deals this week: Ambarella, MarketAxess, argenx SE, TransDigm, and more
Dimensional Fund Advisors LP Sells 35,893 Shares of Lantheus Holdings, Inc. $LNTH
Curium in talks to buy Lantheus Holdings for about $7B - Bloomberg
Lantheus receives Complete Response Letter for LNTH-2501
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Lantheus (LNTH) Q1 2026 Earnings Transcript
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results
LNTH: Lantheus Reports 1Q:26 Financial and Operational Results
Lantheus reiterates $1.4B-$1.45B 2026 revenue outlook while targeting PYLARIFY TRUVU transition in Q4
Lantheus Holdings Non-GAAP EPS of $1.46 beats by $0.23, revenue of $377.3M beats by $22.88M
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
Lantheus Holdings Q1 2026 Earnings Preview
Bayforest Capital Ltd Sells 10,574 Shares of Lantheus Holdings, Inc. $LNTH
Lantheus Holdings, Inc. $LNTH Shares Sold by Allspring Global Investments Holdings LLC
Lantheus Holdings, Inc. (NASDAQ:LNTH) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Assenagon Asset Management S.A. Trims Position in Lantheus Holdings, Inc. $LNTH
CWA Asset Management Group LLC Makes New $1.67 Million Investment in Lantheus Holdings, Inc. $LNTH
Lantheus says FDA extended review period for radioactive diagnostic kit
Brokerages Set Lantheus Holdings, Inc. (NASDAQ:LNTH) PT at $82.17
Why Lantheus Holdings Stock Popped by Almost 12% Last Month
Korn Ferry, Hewlett Packard Enterprise And 3 Stocks To Watch Heading Into Monday
American Century Companies Inc. Sells 341,642 Shares of Lantheus Holdings, Inc. $LNTH
Elo Mutual Pension Insurance Co Acquires New Stake in Lantheus Holdings, Inc. $LNTH
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
Dana Investment Advisors Inc. Sells 13,875 Shares of Lantheus Holdings, Inc. $LNTH
LNTH: 2025 Earnings Flash Report
Lantheus outlines $1.4B–$1.45B 2026 revenue forecast as company shifts focus to PET radiodiagnostics
Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call Transcript
Lantheus Holdings reports mixed Q4 results; introduces FY26 outlook
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Here are the major earnings before the open Thursday
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
Stanley Laman Group Ltd. Acquires 22,229 Shares of Lantheus Holdings, Inc. $LNTH
VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stock Position in Lantheus Holdings, Inc. $LNTH
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
Osaic Holdings Inc. Boosts Holdings in Lantheus Holdings, Inc. $LNTH
E. Ohman J or Asset Management AB Buys 10,506 Shares of Lantheus Holdings, Inc. $LNTH
Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year
This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year
Frontier Capital Management Co. LLC Purchases 108,060 Shares of Lantheus Holdings, Inc. $LNTH
Cresset Asset Management LLC Sells 16,922 Shares of Lantheus Holdings, Inc. $LNTH
Lantheus Holdings, Inc. $LNTH Shares Sold by Federated Hermes Inc.
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)
Boston Partners Boosts Position in Lantheus Holdings, Inc. $LNTH
Creative Planning Decreases Stock Position in Lantheus Holdings, Inc. $LNTH